PIK3CA and colorectal carcinoma: A direct predictive value of PIK3CA mutations for Cetuximab resistance is still controversially discussed [55, 56], but PIK3CA mutations were reported by others to e.g. also significantly correlate with lower progression free and overall survival of CRC patients [7].